Find the Perfect Plan for Your Investment Journey
G
Latest price
52 Week Range
DKK1.16K - DKK2.09K
Next Earnings Date
May 08 2025
Next Earnings Date
May 08 2025
Latest price
Market Cap | DKK83.50B |
EV | DKK63.43B |
Shares Outstanding | 62.31M |
Beta | 0.96 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | DKK2081.92 |
P/E 2025E | 12.92x |
P/Revenue 2025E | 3.39x |
Revenue | 36.40% |
EPS | 40.10% |
Operating Cash Flow | 51.70% |
Free Cash Flow | 56.60% |
Revenue | 15.10% |
EPS | 5.70% |
Operating Cash Flow | 8.70% |
Free Cash Flow | 7.90% |
Gross Margin 2025E | 94.75% |
Net Profit Margin 2025E | 27.41% |
ROE 2025E | 16.32% |
ROCE 2024 | 22.97% |
DPS 2025E | DKK0.00 |
Payout Ratio 2025E | 0.00% |
Div. Yield 2025E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
G
Genmab A/S
GMAB
Sector
Healthcare
Industry
Biotechnology
CEO
de Winkel, Jan G.J.
Employees
2,682
Website
www.genmab.comIPO Date
2000-10-20
Headquarters
Carl Jacobsens Vej 30, Valby, Copenhagen, Capital Region of Denmark, 2500, Denmark
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved